Use of electronic cigarettes in the perioperative period

A mixed-method study exploring perceptions of cardiothoracic patients in Australia

Nia A. Luxton, Patti Shih, Muhammad Aziz Rahman, Roger Adams, Ross MacKenzie

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Electronic cigarettes (e-cigarettes) may reduce tobacco use and achieve tobacco abstinence in the perioperative period of cardiothoracic surgery for patients who smoke. However, research on patients' views on the role of e-cigarettes as a smoking cessation tool is lacking. This mixed-methods study explored perceptions on the use of e-cigarettes among current smokers and ex-smokers awaiting cardiothoracic surgery in Australia. METHODS: A cross-sectional study and semi-structured interviews were conducted with 62 patients who were diagnosed with coronary artery disease or lung cancer and were scheduled for elective cardiothoracic surgery at six metropolitan hospitals in Sydney. Data were collected on demographic characteristics, smoking history, surgical risk index, self-efficacy, interest in, perceived benefits of, and barriers to using e-cigarettes in the perioperative period. RESULTS: Current smokers reported significantly higher interest in the use of e-cigarettes (p=0.008), and perceived fewer barriers (p=0.048) and more health benefits (p=0.079), compared to ex-smokers. Current smokers considered e-cigarettes to be either a safer alternative to tobacco or a novel method for quitting. Recent ex-smokers, defined as those who quit 2-8 weeks, were a distinct group with high nicotine dependency, a long history of smoking, and multiple failed quit attempts. Compared to longer-term ex-smokers (8-52 weeks quit), recent ex-smokers were more interested in e-cigarettes (p=0.029) and considered e-cigarettes a useful aid to prevent relapse in the lead up to surgery and to manage their nicotine cravings. CONCLUSIONS: E-cigarettes may be considered a short-term novel aid and a bridge to evidence-based methods to reduce harm from continued tobacco use for some patients awaiting cardiothoracic surgery for coronary artery disease or lung cancer. This study presents reasons why patients awaiting cardiothoracic surgery may enquire about or use e-cigarettes, which will help clinicians identify those who need more consistent, sustained cessation support.

Original languageEnglish
Article number98957
Pages (from-to)1-11
Number of pages11
JournalTobacco Induced Diseases
Volume16
Issue number11
DOIs
Publication statusPublished - 1 Nov 2018
Externally publishedYes

Fingerprint

Perioperative Period
electronics
surgery
nicotine
smoking
Tobacco Use
Nicotine
Tobacco
cancer
Coronary Artery Disease
Lung Neoplasms
Smoking
Disease
Electronic Cigarettes
relapse
Urban Hospitals
cross-sectional study
Insurance Benefits
Smoking Cessation
Self Efficacy

Cite this

Luxton, Nia A. ; Shih, Patti ; Rahman, Muhammad Aziz ; Adams, Roger ; MacKenzie, Ross. / Use of electronic cigarettes in the perioperative period : A mixed-method study exploring perceptions of cardiothoracic patients in Australia. In: Tobacco Induced Diseases. 2018 ; Vol. 16, No. 11. pp. 1-11.
@article{6abf940d24684aba8deaf53bf4fe07ac,
title = "Use of electronic cigarettes in the perioperative period: A mixed-method study exploring perceptions of cardiothoracic patients in Australia",
abstract = "INTRODUCTION: Electronic cigarettes (e-cigarettes) may reduce tobacco use and achieve tobacco abstinence in the perioperative period of cardiothoracic surgery for patients who smoke. However, research on patients' views on the role of e-cigarettes as a smoking cessation tool is lacking. This mixed-methods study explored perceptions on the use of e-cigarettes among current smokers and ex-smokers awaiting cardiothoracic surgery in Australia. METHODS: A cross-sectional study and semi-structured interviews were conducted with 62 patients who were diagnosed with coronary artery disease or lung cancer and were scheduled for elective cardiothoracic surgery at six metropolitan hospitals in Sydney. Data were collected on demographic characteristics, smoking history, surgical risk index, self-efficacy, interest in, perceived benefits of, and barriers to using e-cigarettes in the perioperative period. RESULTS: Current smokers reported significantly higher interest in the use of e-cigarettes (p=0.008), and perceived fewer barriers (p=0.048) and more health benefits (p=0.079), compared to ex-smokers. Current smokers considered e-cigarettes to be either a safer alternative to tobacco or a novel method for quitting. Recent ex-smokers, defined as those who quit 2-8 weeks, were a distinct group with high nicotine dependency, a long history of smoking, and multiple failed quit attempts. Compared to longer-term ex-smokers (8-52 weeks quit), recent ex-smokers were more interested in e-cigarettes (p=0.029) and considered e-cigarettes a useful aid to prevent relapse in the lead up to surgery and to manage their nicotine cravings. CONCLUSIONS: E-cigarettes may be considered a short-term novel aid and a bridge to evidence-based methods to reduce harm from continued tobacco use for some patients awaiting cardiothoracic surgery for coronary artery disease or lung cancer. This study presents reasons why patients awaiting cardiothoracic surgery may enquire about or use e-cigarettes, which will help clinicians identify those who need more consistent, sustained cessation support.",
keywords = "Coronary artery disease, E-cigarettes, Lung cancer, Patient perceptions, Preoperative",
author = "Luxton, {Nia A.} and Patti Shih and Rahman, {Muhammad Aziz} and Roger Adams and Ross MacKenzie",
year = "2018",
month = "11",
day = "1",
doi = "10.18332/tid/98957",
language = "English",
volume = "16",
pages = "1--11",
journal = "Tobacco Induced Diseases",
issn = "1617-9625",
publisher = "BioMed Central",
number = "11",

}

Use of electronic cigarettes in the perioperative period : A mixed-method study exploring perceptions of cardiothoracic patients in Australia. / Luxton, Nia A.; Shih, Patti; Rahman, Muhammad Aziz; Adams, Roger; MacKenzie, Ross.

In: Tobacco Induced Diseases, Vol. 16, No. 11, 98957, 01.11.2018, p. 1-11.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use of electronic cigarettes in the perioperative period

T2 - A mixed-method study exploring perceptions of cardiothoracic patients in Australia

AU - Luxton, Nia A.

AU - Shih, Patti

AU - Rahman, Muhammad Aziz

AU - Adams, Roger

AU - MacKenzie, Ross

PY - 2018/11/1

Y1 - 2018/11/1

N2 - INTRODUCTION: Electronic cigarettes (e-cigarettes) may reduce tobacco use and achieve tobacco abstinence in the perioperative period of cardiothoracic surgery for patients who smoke. However, research on patients' views on the role of e-cigarettes as a smoking cessation tool is lacking. This mixed-methods study explored perceptions on the use of e-cigarettes among current smokers and ex-smokers awaiting cardiothoracic surgery in Australia. METHODS: A cross-sectional study and semi-structured interviews were conducted with 62 patients who were diagnosed with coronary artery disease or lung cancer and were scheduled for elective cardiothoracic surgery at six metropolitan hospitals in Sydney. Data were collected on demographic characteristics, smoking history, surgical risk index, self-efficacy, interest in, perceived benefits of, and barriers to using e-cigarettes in the perioperative period. RESULTS: Current smokers reported significantly higher interest in the use of e-cigarettes (p=0.008), and perceived fewer barriers (p=0.048) and more health benefits (p=0.079), compared to ex-smokers. Current smokers considered e-cigarettes to be either a safer alternative to tobacco or a novel method for quitting. Recent ex-smokers, defined as those who quit 2-8 weeks, were a distinct group with high nicotine dependency, a long history of smoking, and multiple failed quit attempts. Compared to longer-term ex-smokers (8-52 weeks quit), recent ex-smokers were more interested in e-cigarettes (p=0.029) and considered e-cigarettes a useful aid to prevent relapse in the lead up to surgery and to manage their nicotine cravings. CONCLUSIONS: E-cigarettes may be considered a short-term novel aid and a bridge to evidence-based methods to reduce harm from continued tobacco use for some patients awaiting cardiothoracic surgery for coronary artery disease or lung cancer. This study presents reasons why patients awaiting cardiothoracic surgery may enquire about or use e-cigarettes, which will help clinicians identify those who need more consistent, sustained cessation support.

AB - INTRODUCTION: Electronic cigarettes (e-cigarettes) may reduce tobacco use and achieve tobacco abstinence in the perioperative period of cardiothoracic surgery for patients who smoke. However, research on patients' views on the role of e-cigarettes as a smoking cessation tool is lacking. This mixed-methods study explored perceptions on the use of e-cigarettes among current smokers and ex-smokers awaiting cardiothoracic surgery in Australia. METHODS: A cross-sectional study and semi-structured interviews were conducted with 62 patients who were diagnosed with coronary artery disease or lung cancer and were scheduled for elective cardiothoracic surgery at six metropolitan hospitals in Sydney. Data were collected on demographic characteristics, smoking history, surgical risk index, self-efficacy, interest in, perceived benefits of, and barriers to using e-cigarettes in the perioperative period. RESULTS: Current smokers reported significantly higher interest in the use of e-cigarettes (p=0.008), and perceived fewer barriers (p=0.048) and more health benefits (p=0.079), compared to ex-smokers. Current smokers considered e-cigarettes to be either a safer alternative to tobacco or a novel method for quitting. Recent ex-smokers, defined as those who quit 2-8 weeks, were a distinct group with high nicotine dependency, a long history of smoking, and multiple failed quit attempts. Compared to longer-term ex-smokers (8-52 weeks quit), recent ex-smokers were more interested in e-cigarettes (p=0.029) and considered e-cigarettes a useful aid to prevent relapse in the lead up to surgery and to manage their nicotine cravings. CONCLUSIONS: E-cigarettes may be considered a short-term novel aid and a bridge to evidence-based methods to reduce harm from continued tobacco use for some patients awaiting cardiothoracic surgery for coronary artery disease or lung cancer. This study presents reasons why patients awaiting cardiothoracic surgery may enquire about or use e-cigarettes, which will help clinicians identify those who need more consistent, sustained cessation support.

KW - Coronary artery disease

KW - E-cigarettes

KW - Lung cancer

KW - Patient perceptions

KW - Preoperative

UR - http://www.scopus.com/inward/record.url?scp=85056586819&partnerID=8YFLogxK

U2 - 10.18332/tid/98957

DO - 10.18332/tid/98957

M3 - Article

VL - 16

SP - 1

EP - 11

JO - Tobacco Induced Diseases

JF - Tobacco Induced Diseases

SN - 1617-9625

IS - 11

M1 - 98957

ER -